The FDA has approved the first drug that directly targets Alexander disease, a devastating neurological disorder affecting fewer than one in a million people. Developed through decades of research, Zanvastro showed promising results in clinical trials, stabilizing motor function and even improving movement in some patients.
More in Research
Ozempic and Wegovy linked to rare risk of sudden vision loss
October 15, 2026
A 47-year study reveals the age when your body starts losing strength
October 15, 2026
Scientists reveal 93% of Australia's Indigenous population was lost in just 73 years
October 14, 2026
A forgotten fossil reveals a fearsome dinosaur with giant claws
October 14, 2026
Cancer is rising in younger adults, and scientists can't fully explain why
October 14, 2026
Scientists reveal why some workout recovery tricks can backfire
October 14, 2026
Latest News
Trans people should use hospital spaces according to biological sex, NHS England says
October 15, 2026
‘Street Fighter’ Review: Noah Centineo Stars in a Video Game Adaptation That Pummels You With Fan Service and (Too Few) New Moves
October 15, 2026
Why Did Pablo Torre Want to Investigate Kelly Clarkson’s Birdgate? “This Had the Making of a Modern Morality Play”
October 15, 2026
Russell Brand Accuser Says Alleged Rape Left Her Feeling “Dirty” and in Fear She Was Pregnant
October 15, 2026
Court grants two-day police custody of ‘Gem Granites’ Veeramani
October 15, 2026
Material Memoir: Chennai artists explore memory through transformed materials
October 15, 2026